Panelist during the opening session of the DIA Annual Meeting last week stressed the need to work collaboratively, bringing patients into the fold as co-creators of clinical trials to ‘create a whole new landscape for research.’
In the era of big data, the industry is working to address the ethical concerns of integrating patient information into the health care landscape – though a key challenge will be reaching a consensus on what constitutes reliable evidence.
The latest ethical reputations of the world's largest
pharmaceutical companies have been revealed, with GlaxoSmithKline
(GSK) emerging as big pharma's Mother Theresa, according to a
recently-released compilation by Geneva-based...
Researchers have uncovered a novel treatment that could prove to be
effective against tuberculosis (TB), a disease that has made a
comeback due to the emergence of resistant strains of the offending
bacterium and the spread of AIDS.